No AccessJournal of UrologyReview Article1 Oct 2021Reply by Authorsis a reply to letterEditorial CommentEditorial Comment Katharina Beyer, Ravi Barod, Louis Fox, Mieke Van Hemelrijck, and Netty Kinsella Katharina BeyerKatharina Beyer *Correspondence: Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Studies, 3rd Floor, Bermondsey Wing, Guy's Hospital, Great Maze Pond, London SE1 9RT telephone: 02071885594; E-mail Address: [email protected] Translational Oncology and Urology Research (TOUR), King's College London, London, UK Financial and/or other relationship with Kidney Cancer UK and Royal Marsden Charity. More articles by this author , Ravi BarodRavi Barod Specialist Centre for Kidney Cancer, Royal Free Hospital, London, UK More articles by this author , Louis FoxLouis Fox Translational Oncology and Urology Research (TOUR), King's College London, London, UK More articles by this author , Mieke Van HemelrijckMieke Van Hemelrijck Translational Oncology and Urology Research (TOUR), King's College London, London, UK Financial and/or other relationship with Kidney Cancer UK. More articles by this author , and Netty KinsellaNetty Kinsella Translational Oncology and Urology Research (TOUR), King's College London, London, UK Department of Urology, Royal Marsden Hospital, London, UK Financial and/or other relationship with Kidney Cancer UK. More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001901.03AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Reply by Authors." The Journal of Urology, 206(4), p. 839 Research funding: Royal Marsden Charity; Kidney Cancer UK. Grant Number: MVH220219. References 51 through 77 can be obtained at https://www.jurology.com. © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology21 Jul 2021Editorial CommentJournal of Urology21 Jul 2021Editorial Comment Volume 206Issue 4October 2021Page: 839-839 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Katharina Beyer Translational Oncology and Urology Research (TOUR), King's College London, London, UK *Correspondence: Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Studies, 3rd Floor, Bermondsey Wing, Guy's Hospital, Great Maze Pond, London SE1 9RT telephone: 02071885594; E-mail Address: [email protected] Financial and/or other relationship with Kidney Cancer UK and Royal Marsden Charity. More articles by this author Ravi Barod Specialist Centre for Kidney Cancer, Royal Free Hospital, London, UK More articles by this author Louis Fox Translational Oncology and Urology Research (TOUR), King's College London, London, UK More articles by this author Mieke Van Hemelrijck Translational Oncology and Urology Research (TOUR), King's College London, London, UK Financial and/or other relationship with Kidney Cancer UK. More articles by this author Netty Kinsella Translational Oncology and Urology Research (TOUR), King's College London, London, UK Department of Urology, Royal Marsden Hospital, London, UK Financial and/or other relationship with Kidney Cancer UK. More articles by this author Expand All Research funding: Royal Marsden Charity; Kidney Cancer UK. Grant Number: MVH220219. References 51 through 77 can be obtained at https://www.jurology.com. Advertisement PDF downloadLoading ...